Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has acted as legal adviser to Deutsche Bank, Citigroup Global Markets and Nordea in connection with the establishment of Vattenfall’s Swedish EMTN programme.
Mandate

Vinge has acted as legal adviser to Deutsche Bank, Citigroup Global Markets and Nordea in connection with the establishment of Vattenfall’s Swedish EMTN programme.

May 15, 2018 Banking and Finance

The EMTN programme enables Vattenfall to continuously issue notes within a maximum outstanding nominal amount of EUR 10 billion at each time.

The EMTN programme is the first ever to be established under Swedish law. Deutsche Bank AG, London Branch is acting as arranger and Deutsche Bank AG, London Branch, Citigroup Global Markets Limited and Nordea Bank AB (publ) are appointed as dealers under the programme. The prospectus was approved by the Swedish Financial Supervisory Authority on 18 April 2018.

Vinge’s team consisted of partner Mikael Ståhl together with Josefine Larsson and Sara Osman.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025